In a short overview we show how our technology stacks up versus competitive methods.
We have achieved facile production of a variety of microbeads including: single and double emulsions, Janus hydrogel beads and cell capsules.
For drug microparticles to be efficient, their size, shape, and content are key parameters. In IamFluidics we have achieved >90% monodispersity in all aspects, while ensuring sterility, without surfactants.
1 The type of production and typical production rate. 2 The relative spread in product size. Monodisperse (i.e., mono-sized) products give more predictable and consistent results. 3 The amount of active ingredient that is encapsulated and thus contributes to the end product. 4 The amount of product that does not meet the required specification. 5 The ability reproduce the outcome of the production process. 6 The level of technical expertise that is required to install and/or operate the system.
Conventional chip based microfluidics can produce microbeads at the rate of μl/min. With IAMF we can produce monodisperse emulsions, particles, and fibers with controlled shaped and size (10 to 300μm) with a production rate of ml/min with a single setup. That is 1000x times faster.
Get to know our services
For the first time, we connect and integrate the fields of microfluidics and additive manufacturing, by presenting a unifying technology that we call In-air microfluidics (IAMF).